Clinical Trial Update: Efficacy of Zinc L-carnosine in Maintaining Remission of Gastroesophageal Reflux Disease [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating zinc L-carnosine for maintaining remission in gastroesophageal reflux disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Zinc-L-carnosine (zinc-L-carnosine)

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: Gastroesophageal Reflux Disease | Phase 4 | Status: UNKNOWN